Akoya Biosciences, Inc. (AKYA)
USD 1.04
(-11.54%)
USD 1.04
(-11.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -63.32 Million USD | 10.36% |
| 2022 | -70.64 Million USD | -64.53% |
| 2021 | -42.93 Million USD | -157.0% |
| 2020 | -16.7 Million USD | -13.25% |
| 2019 | -14.75 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -13.14 Million USD | 44.01% |
| 2024 Q1 | -23.48 Million USD | -117.4% |
| 2023 Q4 | -10.8 Million USD | 16.37% |
| 2023 FY | -63.32 Million USD | 10.36% |
| 2023 Q3 | -12.91 Million USD | 37.91% |
| 2023 Q2 | -20.8 Million USD | -10.64% |
| 2023 Q1 | -18.8 Million USD | 0.39% |
| 2022 Q2 | -17.49 Million USD | -6.68% |
| 2022 Q1 | -16.39 Million USD | 7.21% |
| 2022 FY | -70.64 Million USD | -64.53% |
| 2022 Q4 | -18.87 Million USD | -5.61% |
| 2022 Q3 | -17.87 Million USD | -2.15% |
| 2021 Q1 | -8.08 Million USD | -41.94% |
| 2021 FY | -42.93 Million USD | -157.0% |
| 2021 Q4 | -17.67 Million USD | -52.13% |
| 2021 Q3 | -11.61 Million USD | -108.83% |
| 2021 Q2 | -5.56 Million USD | 31.17% |
| 2020 FY | -16.7 Million USD | -13.25% |
| 2020 Q4 | -5.69 Million USD | -32.91% |
| 2020 Q3 | -4.28 Million USD | 6.56% |
| 2020 Q2 | -4.58 Million USD | -113.95% |
| 2020 Q1 | -2.14 Million USD | 0.0% |
| 2019 FY | -14.75 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AngioDynamics, Inc. | -184.34 Million USD | 65.65% |
| AtriCure, Inc. | -30.43 Million USD | -108.039% |
| Avinger, Inc. | -18.32 Million USD | -245.65% |
| Azenta, Inc. | -14.25 Million USD | -344.154% |
| BioLife Solutions, Inc. | -66.42 Million USD | 4.673% |
| The Cooper Companies, Inc. | 294.2 Million USD | 121.524% |
| Daxor Corporation | 280.64 Thousand USD | 22663.783% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -316.654% |
| Femasys Inc. | -14.24 Million USD | -344.462% |
| GlucoTrack, Inc. | -7.09 Million USD | -792.25% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -1754.261% |
| Hologic, Inc. | 789.5 Million USD | 108.021% |
| ICU Medical, Inc. | -29.65 Million USD | -113.532% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 103.522% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -360.83% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 310.34% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -850.307% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -850.307% |
| Masimo Corporation | 81.5 Million USD | 177.697% |
| Microbot Medical Inc. | -10.74 Million USD | -489.6% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 644.694% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 167.072% |
| Nephros, Inc. | -1.57 Million USD | -3920.508% |
| NovoCure Limited | -207.04 Million USD | 69.416% |
| NEXGEL, Inc. | -3.15 Million USD | -1905.797% |
| NEXGEL, Inc. | -3.15 Million USD | -1905.797% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 33.218% |
| OraSure Technologies, Inc. | 53.65 Million USD | 218.019% |
| Pro-Dex, Inc. | 2.12 Million USD | 3077.104% |
| Pulse Biosciences, Inc. | -42.21 Million USD | -50.019% |
| Predictive Oncology Inc. | -13.98 Million USD | -352.826% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -2045.541% |
| QuidelOrtho Corporation | -10.1 Million USD | -526.96% |
| Repligen Corporation | 41.57 Million USD | 252.303% |
| Sanara MedTech Inc. | -4.3 Million USD | -1371.534% |
| STAAR Surgical Company | 21.34 Million USD | 396.637% |
| Sharps Technology, Inc. | -9.84 Million USD | -543.419% |
| Utah Medical Products, Inc. | 16.63 Million USD | 480.661% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 52.028% |
| Jin Medical International Ltd. | 2.87 Million USD | 2300.067% |